Morpholine → HCID 59525697, compound
Reaction equation
[Br:1][C:2]1[N:7]=[C:6]([CH2:8][O:9][CH2:10][C:11]([OH:13])=O)[CH:5]=[CH:4][CH:3]=1.[NH:14]1[CH2:19][CH2:18][O:17][CH2:16][CH2:15]1.C(N(C(C)C)C(C)C)C.O.ON1C2C=CC=CC=2N=N1.Cl.CN(C)CCCN=C=NCC>ClCCl>[Br:1][C:2]1[N:7]=[C:6]([CH2:8][O:9][CH2:10][C:11]([N:14]2[CH2:19][CH2:18][O:17][CH2:16][CH2:15]2)=[O:13])[CH:5]=[CH:4][CH:3]=1Participants
7
Reactant 5
Product 1
Reagents, catalysts & solvents 1
Procedure
To a solution of [(6-bromopyridin-2-yl)methoxy]acetic acid (1.6 g, 7.5 mmol) and morpholine (0.65 g, 7.5 mmol) in dichloromethane at 0° C. was added N-ethyl-N-isopropylpropan-2-amine (3.9 mL, 22.5 mmol), 1-hydroxybenzotriazole hydrate (1.5 g, 11.25 mmol) and 1-(3-dimethylaminopropyl)-3-ethylcarbodiimide hydrochloride (2.1 g, 11.25 mmol). The reaction mixture was stirred at room temperature overnight. The reaction solution was concentrated under reduced pressure, and the resulting residue was purified by silica gel column chromatography, eluting with ethyl acetate:hexanes (3:7) to afford the title compound.
Workup
- concentrationThe reaction solution was concentrated under reduced pressure
- customthe resulting residue was purified by silica gel column chromatography
- washeluting with ethyl acetate:hexanes (3:7)
Sources & evidence
- ORD record
- ord-53ddbcbc9fa44a0187090a080a71e43a
- Source dataset
- uspto-grants-2013_02
- Patent number
- US08367706B2
Reaction notes
Loading…